haloperidol has been researched along with 22q11 Deletion Syndrome in 1 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
22q11 Deletion Syndrome: Condition with a variable constellation of phenotypes due to deletion polymorphisms at chromosome location 22q11. It encompasses several syndromes with overlapping abnormalities including the DIGEORGE SYNDROME, VELOCARDIOFACIAL SYNDROME, and CONOTRUNCAL AMOMALY FACE SYNDROME. In addition, variable developmental problems and schizoid features are also associated with this syndrome. (From BMC Med Genet. 2009 Feb 25;10:16) Not all deletions at 22q11 result in the 22q11deletion syndrome.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In previous animal studies of psychiatric disorders associated with 22q11." | 1.62 | Two novel mouse models mimicking minor deletions in 22q11.2 deletion syndrome revealed the contribution of each deleted region to psychiatric disorders. ( Aiba, A; Funato, H; Koebis, M; Kushima, I; Miyoshi, C; Mori, D; Nakao, K; Ozaki, N; Saito, R; Yanagisawa, M, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Saito, R | 1 |
| Miyoshi, C | 1 |
| Koebis, M | 1 |
| Kushima, I | 1 |
| Nakao, K | 1 |
| Mori, D | 1 |
| Ozaki, N | 1 |
| Funato, H | 1 |
| Yanagisawa, M | 1 |
| Aiba, A | 1 |
1 other study available for haloperidol and 22q11 Deletion Syndrome
| Article | Year |
|---|---|
Two novel mouse models mimicking minor deletions in 22q11.2 deletion syndrome revealed the contribution of each deleted region to psychiatric disorders.
Topics: 22q11 Deletion Syndrome; Animals; Base Sequence; Behavior, Animal; Circadian Rhythm; Conditioning, C | 2021 |